Skip to content
OpenCapital
Get started

Baxter International BAX Medical Products & Therapies — Net Sales

Other segment segments

Healthcare Systems & Technologies
$705M+0.1%
Pharmaceuticals
$621M+6.9%

Similar metrics at other companies

Moog Inc. logo
MOG.BMedical Devices — Net Revenue
$25.93M+0.8%
STERIS logo
STEProduct — Revenue
$845.3M+5.5%
Chart Industries logo
GTLSBiomedical — Revenue
$56.59M+14.0%
Fortive logo
FTVMedical technologies — Sales
$308.1M+12.4%
Boston Scientific logo
BSXMedSurg — Net sales of reportable segments
$1.7B+5.7%
Zimmer Biomet Holdings logo
ZBHOther Product Category — Revenue
$143.4M-9.7%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's medical products & therapies — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's medical products & therapies — net sales?
Baxter International (BAX) reported medical products & therapies — net sales of $1.29B in Q1 2026.
How has Baxter International's medical products & therapies — net sales changed year-over-year?
Baxter International's medical products & therapies — net sales increased by 1.8% year-over-year, from $1.26B to $1.29B.
What is the long-term trend for Baxter International's medical products & therapies — net sales?
Over 3 years (2021 to 2025), Baxter International's medical products & therapies — net sales has grown at a 3.2% compound annual growth rate (CAGR), from $4.82B to $5.3B.
What does medical products & therapies — net sales mean?
Total revenue earned by this business segment after accounting for returns and discounts.
How do you interpret medical products & therapies — net sales?
Higher sales indicate strong market adoption and effective commercial execution.
How does medical products & therapies — net sales compare across companies?
Standard revenue metric used by all public companies to measure segment performance.